NutriBand (NTRB) Total Non-Current Liabilities (2019 - 2024)
NutriBand (NTRB) posted Total Non-Current Liabilities of $1.5 million for Q2 2024, up 83.73% sequentially from $811738.0 in Q4 2023.
NutriBand (NTRB) Total Non-Current Liabilities (2019 - 2024) Analysis & Trends
NutriBand has reported Total Non-Current Liabilities for 4 years, with the latest figure at $1.5 million in Q2 2024.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $1.5 million in Q2 2024, while the trailing twelve-month figure through Apr 2024 was $1.5 million (changed N/A YoY) and the FY2020 annual result came in at $1.1 million, changed N/A from the prior year.
- Total Non-Current Liabilities advanced to $1.5 million in Q2 2024 per NTRB's latest filing, from $811738.0 in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $2.8 million in Q4 2020 and troughed at $811738.0 in Q4 2023.
- A 3-year average of $1.6 million and a median of $1.3 million in 2020 frame the typical range for Total Non-Current Liabilities.
- The widest YoY moves for Total Non-Current Liabilities: up 44.03% in 2020, down 38.23% in 2020.
- Over 3 years, Total Non-Current Liabilities stood at $2.8 million in 2020, then slumped by 71.27% to $811738.0 in 2023, then jumped by 83.73% to $1.5 million in 2024.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.5 million, $811738.0, and $2.8 million for Q2 2024, Q4 2023, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 40.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 3.92 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.88 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 724.15 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.17 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.32 Bn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2024 | 1.49 Mn |
| Oct 31, 2023 | 811,738.00 |
| Oct 31, 2020 | 2.83 Mn |
| Jul 31, 2020 | 902,632.00 |
| Apr 30, 2020 | 2.20 Mn |
| Jan 31, 2020 | 1.09 Mn |
| Oct 31, 2019 | 1.96 Mn |
| Apr 30, 2019 | 1.59 Mn |